Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Comment by LithLoveron Nov 08, 2021 11:56am
110 Views
Post# 34100210

RE:RE:RE:RE:RE:New documents out on Sedar- Nov 8

RE:RE:RE:RE:RE:New documents out on Sedar- Nov 8 Happy to.  On Page 9 of today's (Nov 8, 2021 Management Information circular - English) :

TSX Conditional Approval

On August 27, 2021, the Corporation received TSX Conditional Approval for the notice of Transaction and the listing of the shares, including the Contingent Shares, to be issued as consideration pursuant to the Transaction, subject to the Corporation fulfilling all of the conditions set out therein



And from that TSX Form 51-102F3 Material Change Report on Sedar Aug 30,2021

8,000,000 common shares contingent upon the achievement of certain milestones (“Milestones”) and StageZero shareholder approval (the “Contingent Shares”). In the event the Milestones are achieved, and the StageZero shareholders do not approve of the issuance of the Contingent Shares, StageZero is obligated to pay to Health Clinics Limited, in lieu of the Contingent Shares, CAD $16,000,000, payable at a rate of 9.5% out of StageZero’s monthly gross revenues. The Contingent Consideration becomes immediately payable in the event of a take-over bid.

------------
The forms have been filed with the TSX.  Depending on the upcoming shareholder vote, once milestones are achieved iit's a just a matter of how they compensate them.  Will it be an issuing of an additional 8 million shares or payout $16 million in payments as outlined.




molotov420 wrote: Can you please explain this to me. The original details of the acquisition showed this:

"8,000,000 common shares contingent upon the achievement of certain milestones ("Milestones") and StageZero shareholder approval (the "Contingent Shares")."

In todays news page 9 in the background section it says:


"The Corporation also agreed to issue an additional 8,000,000 Common Shares (the “Contingent Shares”) to Health Clinics Limited, contingent upon the Corporation’s obtaining shareholder approval of the issuance"

why no mention of milestones this time?! did they forget about the milestones?


<< Previous
Bullboard Posts
Next >>